Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE

(SHP)
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Analyst Recommendations on SHIRE
2018Takeda Shareholders Approve Shire Megadeal -- WSJ
DJ
2018Takeda clears key hurdle as investors back $59 billion Shire deal
RE
2018Takeda investors back $59 billion Shire deal, but wary of debt load
RE
2018Takeda hikes annual profit outlook by a third after second quarter profit jum..
RE
2018SHIRE PLC : quaterly earnings release
2018Beset by copies, Roche gets sales boost from China
RE
2018Takeda operating profit halves, looks to asset sales to shore up finances
RE
2018Barclays Poaches Senior Health-Care Banker From Deutsche Bank
DJ
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in fa..
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in fa..
RE
2018Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal
RE
2018Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal
RE
2018Novartis top lawyer exits over Trump attorney deal 'mistake'
RE
2018Novartis top lawyer exits over Trump attorney deal 'mistake'
RE
2018Takeda sees lower annual profit, generics to erode cancer drug sales
RE
2018Japan's Takeda Wins Fight For Shire -- WSJ
DJ
2018Japan's Takeda clinches £45.3 billion Shire deal as pharma M&A rolls on
RE
2018TAKEDA PHARMACEUTICAL : Offer for Shire -13-
DJ
2018Takeda Pharmaceutical Company Ltd Offer for Shire -7-
DJ
2018Takeda Pharmaceutical Company Ltd Offer for Shire -2-
DJ
2018Takeda Pharmaceutical Company Ltd Offer for Shire plc
DJ
2018Allergan CEO opposes fundamental shift in strategy, shares fall
RE
2018Allergan CEO opposes fundamental shift in strategy, shares fall
RE
2018Overshadowed by Takeda bid, Shire reports solid start to year
RE
2018Biosimilar worries takes shine off Roche's guidance hike
RE
2018Takeda Closes In on Shire -- WSJ
DJ
2018Shire willing to back $64 billion Takeda bid, market signals doubts
RE
2018Currency and pricing squeeze GSK as new shingles vaccine shines
RE
2018Shire willing to back $64 billion Takeda bid, market signals doubts
RE
2018Takeda Pharmaceutical Company Ltd Statement regarding Shire plc
DJ
2018Japan's Takeda sweetens $62 billion Shire offer
RE
2018Takeda Pharmaceutical Company Ltd Statement Regarding Improved Proposal for S..
DJ
2018Shire Attracts Flurry Of Suitors -- WSJ
DJ
2018Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
2018Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
2018Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
2018Takeda Pharmaceutical Company Ltd Statement Regarding Shire plc
DJ
2018Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
RE
2018TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
2018TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
2018Takeda sounds out banks for loans as it moves towards Shire bid - sources
RE
2018Novartis bets big on gene therapy with $8.7 billion AveXis deal
RE
2018Novartis bets big on gene therapy with $8.7 billion AveXis deal
RE
2018Novartis bets big on gene therapy with $8.7 billion AveXis deal
RE
2018TAKEDA PHARMACEUTICAL : Statement Regarding Press Reports
DJ
2018Merits of any Takeda bid for Shire questioned, shares slide
RE
2018Merits of any Takeda bid for Shire questioned, shares slide
RE
2018Japan Giant Looks West For Possible Major Deal -- WSJ
DJ
2018Drugmaker Shire soars as Japan's Takeda considers bid
RE
2018ROCHE : Tokyo court rejects Shire claim against Roche haemophilia drug
RE
2018Shire plc 2017 Annual Report - Dtr 6.3.5 And Lr -9-
DJ
2018SHIRE PLC : annual earnings release
2018UK stocks decline as gamblers stumble on government clampdown worries
RE
2018Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
RE
2018New drugs recast $10 billion haemophilia market as Sanofi swoops in
RE
2018SHIRE : cuts 2020 revenue target, prepares for spin-off of ADHD drugs
RE
2018Weak results weigh on FTSE 100, profit warning pummels Mothercare
RE
2017U.S. tax cuts mix pleasure and pain for Europe's dollar earners
RE
2017FTSE falls in broad risk-off move as Trump worries resurface
RE
2017European shares retreat on euro bounce; UK flat after budget
RE
2017FTSE gets sterling boost, land purchase threat dents housebuilders
RE
2017FTSE recoups early losses as cyclicals recover
RE
2017British stocks fall back as Carillion crashes, Sky soars
RE
2017Poor earnings updates keep European shares at seven-week low
RE
2017SHIRE : to make genetic disease drug itself to secure supply
RE
2017FTSE 100 gets sterling boost while Barclays dives after results
RE
2017SHIRE PLC : quaterly earnings release
2017FTSE rises to record close, blue-chips shrug off Reckitt blip
RE
2017Sterling's slip from one-year high curbs FTSE losses
RE
2017SHIRE : defends record as UBS cuts price target on staff satisfaction reviews
RE
2017Retailers wilt on Amazon threat as FTSE inches lower
RE
2017FTSE teeters close to three-month low as financials fall
RE
2017SHIRE : may spin off hyperactivity drugs, raises forecasts
RE
2017SHIRE : Mulls Spinning-off or Selling Neuroscience Unit--Update
DJ
2017SHIRE : Cuts Fiscal Year Outlook for Sales but Raises for Profit on Baxalta Buy
DJ
1  2  3  4Next